Clinical Trial Update: A Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics and Safety and Tolerability of a Single Oral Dose of Risdiplam Compared to Matched Healthy Participants With Normal Hepatic Function [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetics and safety study evaluating hepatic impairment on risdiplam after a single oral dose, comparing impaired participants to matched health…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Muscular Atrophy
• Spinal Muscular Atrophy

Drugs mentioned

• Risdiplam (risdiplam)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Muscular Atrophy, Spinal | Phase 1 | Status: COMPLETED | Results posted: 2021-02-21